Literature DB >> 9721110

The end of triglycerides in cardiovascular risk assessment?. Rumours of death are greatly exaggerated.

N Sattar, C J Packard, J R Petrie.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9721110      PMCID： PMC1113791          DOI： 10.1136/bmj.317.7158.553

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  11 in total

1.  Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men.

Authors:  G Assmann; H Schulte; A von Eckardstein
Journal:  Am J Cardiol       Date:  1996-06-01       Impact factor: 2.778

2.  Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study. Implications for treatment.

Authors:  V Manninen; L Tenkanen; P Koskinen; J K Huttunen; M Mänttäri; O P Heinonen; M H Frick
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

3.  Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?

Authors:  S M Haffner; M P Stern; H P Hazuda; B D Mitchell; J K Patterson
Journal:  JAMA       Date:  1990-06-06       Impact factor: 56.272

4.  Triglyceride concentration and coronary heart disease.

Authors:  A M Garber; A L Avins
Journal:  BMJ       Date:  1994-07-02

5.  A prospective study of triglyceride level, low-density lipoprotein particle diameter, and risk of myocardial infarction.

Authors:  M J Stampfer; R M Krauss; J Ma; P J Blanche; L G Holl; F M Sacks; C H Hennekens
Journal:  JAMA       Date:  1996-09-18       Impact factor: 56.272

Review 6.  What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials?

Authors:  H R Superko
Journal:  Curr Opin Lipidol       Date:  1996-12       Impact factor: 4.776

7.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

Review 8.  Postprandial state and atherosclerosis.

Authors:  C F Ebenbichler; R Kirchmair; C Egger; J R Patsch
Journal:  Curr Opin Lipidol       Date:  1995-10       Impact factor: 4.776

9.  Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM experience). Prospective Cardiovascular Münster study.

Authors:  G Assmann; H Schulte
Journal:  Am J Cardiol       Date:  1992-09-15       Impact factor: 2.778

10.  Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

Authors: 
Journal:  Lancet       Date:  1994-09-03       Impact factor: 79.321
View more
  2 in total

1.  Triacylglycerol-rich lipoproteins alter the secretion, and the cholesterol-effluxing function, of apolipoprotein E-containing lipoprotein particles from human (THP-1) macrophages.

Authors:  E M Lindholm; A M Palmer; A Graham
Journal:  Biochem J       Date:  2001-06-01       Impact factor: 3.857

Review 2.  Inflammation, adiposity, and atherogenic dyslipidemia in rheumatoid arthritis: is there a paradoxical relationship?

Authors:  Ayse Bag-Ozbek; Jon T Giles
Journal:  Curr Allergy Asthma Rep       Date:  2015-02       Impact factor: 4.806
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.